[HTML][HTML] Liver injury in the era of COVID-19

H Cichoż-Lach, A Michalak - World journal of gastroenterology, 2021 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has undoubtedly
revolutionized the whole globe and given a new point of view on respiratory tract infections …

Implications of SARS‐CoV‐2 infection for neurogastroenterology

G Marasco, MV Lenti, C Cremon… - …, 2021 - Wiley Online Library
Abstract Background Coronavirus disease 2019 (COVID‐19) is associated with
gastrointestinal and hepatic manifestation in up to one fifth of patients. Severe acute …

[HTML][HTML] COVID-19: Gastrointestinal manifestations, liver injury and recommendations

Z Ozkurt, EÇ Tanrıverdi - World Journal of Clinical Cases, 2022 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) has caused a pandemic that affected all
countries with nearly 270 million patients and 5 million deaths, as of as of December, 2021 …

The impact of COVID-19 on liver injury

RM Dawood, GM Salum, M Abd El-Meguid - The American Journal of the …, 2022 - Elsevier
The current coronavirus disease outbreak of 2019 (COVID-19) has led to a global pandemic.
The principal cause of mortality in COVID-19 is represented lung injury with the …

Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study

R Galiero, PC Pafundi, V Simeon, L Rinaldi, A Perrella… - PloS one, 2020 - journals.plos.org
Background Italy has been the first Western country to be heavily affected by the spread of
SARS-COV-2 infection and among the pioneers of the clinical management of pandemic. To …

[HTML][HTML] Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission

M Mendizabal, F Pinero, E Ridruejo, M Anders… - Annals of …, 2021 - Elsevier
Introduction & objectives The independent effect of liver biochemistries as a prognostic
factor in patients with COVID-19 has not been completely addressed. We aimed to evaluate …

Abnormal liver biochemistry tests and acute liver injury in COVID-19 patients: current evidence and potential pathogenesis

DA McGrowder, F Miller, M Anderson Cross… - Diseases, 2021 - mdpi.com
Globally, millions of persons have contracted the coronavirus disease 2019 (COVID-19)
over the past several months, resulting in significant mortality. Health care systems are …

High-dose vitamin D supplementation is related to an improvement in serum alkaline phosphatase in COVID-19 patients; a randomized double-blinded clinical trial

RR Moghaddam, Z Khorasanchi, AR Noor… - Journal of Health …, 2023 - Springer
Background The benefits and harms of vitamin D supplementation in the treatment of COVID-
19 have not yet been fully documented. In this study, we aimed to evaluate the effects of high …

[HTML][HTML] Liver injury induced by COVID 19 treatment–what do we know?

L Saha, S Vij, K Rawat - World Journal of Gastroenterology, 2022 - ncbi.nlm.nih.gov
The severity of coronavirus disease 2019 (COVID-19) may be correlated with the risk of liver
injury development. An increasing number of studies indicate that degrees of hepatotoxicity …

Optimal timing of remdesivir initiation in hospitalized patients with coronavirus disease 2019 (COVID-19) administered with dexamethasone

CKH Wong, KTK Lau, ICH Au, X Xiong… - Clinical Infectious …, 2022 - academic.oup.com
Background Evidence is lacking about any additional benefits of introducing remdesivir on
top of dexamethasone, and the optimal timing of initiation. Methods In a territory-wide cohort …